Treatment of Panic Disorder
For panic disorder, the recommended first-line treatment is a combination of Cognitive Behavioral Therapy (CBT) and a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). 1
Pharmacological Treatment
First-Line Medications
- SSRIs and SNRIs are the first-line pharmacological treatments for panic disorder due to their efficacy and favorable side effect profiles 1
Second-Line Medications
- Benzodiazepines like clonazepam may be used:
- For short-term treatment during SSRI/SNRI initiation
- In treatment-resistant cases
- When rapid symptom control is needed
- Clonazepam has demonstrated efficacy in reducing panic attacks (at doses of 1-4 mg/day) 3
- Important caution: Only use benzodiazepines when the patient does not have a history of dependency, as they carry risks of tolerance and dependence 4
Psychotherapy Approach
- Cognitive Behavioral Therapy (CBT) specifically developed for panic disorder is highly effective 1
- Individual therapy is preferred over group therapy
- Key components include:
- Education about panic and anxiety
- Cognitive restructuring to address catastrophic misinterpretations
- Interoceptive exposure to physical sensations
- In vivo exposure to feared situations
- Even brief forms of CBT can be effective 5
Combined Treatment Approach
- Combined CBT and medication is the most successful treatment strategy for panic disorder 4
Treatment Algorithm
Assess severity and functional impairment
- Mild: Consider CBT alone initially
- Moderate to severe: Start combined CBT and SSRI/SNRI
Medication selection
- First-line: SSRI (e.g., paroxetine) or SNRI
- Consider benzodiazepines only for short-term use during SSRI/SNRI initiation or in treatment-resistant cases
Treatment monitoring
- Assess response after 4-6 weeks of medication 1
- If inadequate response:
- Optimize medication dose
- Intensify CBT
- Consider switching to another SSRI/SNRI
- Consider augmentation strategies
Maintenance phase
- Continue effective medication for at least 6-12 months after symptom remission 1
- Taper gradually when discontinuing to avoid withdrawal symptoms
Special Considerations
- Comorbidities are common (depression, other anxiety disorders, substance use) and may require additional targeted interventions 1
- Pregnancy/lactation: SSRIs may be used with caution when benefits outweigh risks 1
- Elderly patients: Start on lower doses and titrate more slowly 1
- Treatment resistance should prompt:
- Reevaluation of diagnosis
- Assessment of medication adherence
- Consideration of alternative or augmentation strategies 1
Common Pitfalls to Avoid
- Premature discontinuation of medication (continue for 6-12 months after remission)
- Rapid benzodiazepine discontinuation (taper slowly to avoid withdrawal)
- Overlooking comorbid conditions that may complicate treatment
- Inadequate dosing of medications (start low but ensure adequate therapeutic dose)
- Failure to combine pharmacotherapy with CBT when indicated
- Not addressing anticipatory anxiety and phobic avoidance that often accompany panic attacks
By following this evidence-based approach, most patients with panic disorder can achieve significant improvement in symptoms and quality of life.